Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer.
Hoffman
Karen E
KE
Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA. khoffman2@mdanderson.org
Chen
Ming-Hui
MH
Moran
Brian J
BJ
Braccioforte
Michelle H
MH
Dosoretz
Daniel
D
Salenius
Sharon
S
Katin
Michael J
MJ
Ross
Rudi
R
D'Amico
Anthony V
AV
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001918:Brachytherapy; D002318:Cardiovascular Diseases / Q000150:complications; D002423:Cause of Death; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000401:mortality* / Q000532:radiotherapy; D050397:Radiotherapy, Intensity-Modulated
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal